Certara Products - Phoenix Archives | Page 2 of 10

Guide

From Numbers to Narrative: Mastering the Art of PK Presentation

Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…

CertaraMarch 20, 2026

Webinar

Pharmacometrics Under Pressure

CertaraMarch 20, 2026

Blog

What are Common Bioequivalence Study Mistakes?

Learn about the most common bioequivalence study mistakes drug developers make and the differences between…

CertaraMarch 20, 2026

Webinar

What is new in Phoenix 8.8?

Danielle PillsburyMarch 9, 2026

Webinar

Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers

CertaraMarch 9, 2026

Guide

Navigate GxP Compliance in the Cloud with Confidence

Master SaaS GxP compliance with risk-based computer system validation (CSV) aligned to GAMP 5, FDA,…

CertaraMarch 6, 2026

Blog Knowledge Base

Understanding and Calculating Steady State Pharmacokinetics

Steady state pharmacokinetics can seem abstract and confusing. Read this blog to gain a better…

CertaraMarch 5, 2026

Live Events

Phoenix Roadshow 2026 – Cambridge

CertaraMarch 2, 2026

Live Events

Phoenix Roadshow 2026 – Raleigh/Durham

CertaraMarch 2, 2026

Live Events

Phoenix Roadshow 2026 – Radnor (Philadelphia area)

CertaraFebruary 27, 2026

Certara Products – Phoenix

From Numbers to Narrative: Mastering the Art of PK Presentation

Pharmacometrics Under Pressure

What are Common Bioequivalence Study Mistakes?

What is new in Phoenix 8.8?

Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers

Navigate GxP Compliance in the Cloud with Confidence

Understanding and Calculating Steady State Pharmacokinetics

Phoenix Roadshow 2026 – Cambridge

Phoenix Roadshow 2026 – Raleigh/Durham

Phoenix Roadshow 2026 – Radnor (Philadelphia area)

Newsletter sign up

Quick links

Solutions

Contact